Arvinas, Inc. (ARVN)
7.46
+0.05
(+0.67%)
USD |
NASDAQ |
Oct 05, 16:00
7.46
0.00 (0.00%)
Pre-Market: 08:21
Arvinas Price to Book Value : 0.8665 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 0.8665 |
| October 02, 2026 | 0.8607 |
| October 01, 2026 | 0.863 |
| September 30, 2026 | 0.8984 |
| September 29, 2026 | 0.8711 |
| September 28, 2026 | 0.8723 |
| September 25, 2026 | 0.8816 |
| September 24, 2026 | 0.9048 |
| September 23, 2026 | 0.9095 |
| September 22, 2026 | 0.9884 |
| September 21, 2026 | 0.9641 |
| September 18, 2026 | 0.9629 |
| September 17, 2026 | 0.9652 |
| September 16, 2026 | 0.9478 |
| September 15, 2026 | 0.9594 |
| September 14, 2026 | 0.9757 |
| September 11, 2026 | 0.9815 |
| September 10, 2026 | 1.012 |
| September 09, 2026 | 1.018 |
| September 08, 2026 | 1.055 |
| September 04, 2026 | 1.091 |
| September 03, 2026 | 1.081 |
| September 02, 2026 | 1.114 |
| September 01, 2026 | 1.078 |
| August 31, 2026 | 1.069 |
| Date | Value |
|---|---|
| August 28, 2026 | 1.066 |
| August 27, 2026 | 1.073 |
| August 26, 2026 | 1.082 |
| August 25, 2026 | 1.115 |
| August 24, 2026 | 1.085 |
| August 21, 2026 | 1.088 |
| August 20, 2026 | 1.048 |
| August 19, 2026 | 1.124 |
| August 18, 2026 | 1.076 |
| August 17, 2026 | 1.069 |
| August 14, 2026 | 1.042 |
| August 13, 2026 | 1.046 |
| August 12, 2026 | 1.030 |
| August 11, 2026 | 1.044 |
| August 10, 2026 | 1.044 |
| August 07, 2026 | 1.016 |
| August 06, 2026 | 1.008 |
| August 05, 2026 | 0.9757 |
| August 04, 2026 | 1.045 |
| August 03, 2026 | 0.9362 |
| July 31, 2026 | 0.9327 |
| July 30, 2026 | 0.9641 |
| July 29, 2026 | 0.9548 |
| July 28, 2026 | 0.9524 |
| July 27, 2026 | 0.9548 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 14.66 |
| CNBX Pharmaceuticals, Inc. | -- |
| Fulcrum Therapeutics, Inc. | 0.9109 |
| Definium Therapeutics, Inc. | 5.299 |
| LeonaBio, Inc. | 1.565 |
Price to Book Value Related Metrics
| PE Ratio | 46.51 |
| PS Ratio | 1.577 |
| Price | 7.46 |
| Earnings Yield | 2.15% |
| Market Cap | 487.14M |
| Normalized PE Ratio | 34.10 |